Characterising acquired resistance to erlotinib in non-small cell lung cancer patients

ABSTRACTIntroduction: The therapy of patients with lung adenocarcinoma has significantly changed after the discovery of epidermal growth factor receptor (EGFR) mutations. EGFR mutations occur in 10...